2018 Announcements

CLINUVEL
Posted by CLINUVEL
July 4, 2018

Change in substantial holding

04 July 2018 Enclosed is a notice of a change in substantial...

Read More
CLINUVEL
Posted by CLINUVEL
June 25, 2018

CLINUVEL COMPLETES SCENESSE® FDA FILING

25 June 2018 EXECUTIVE SUMMARY First NDA for SCENESSE® (afamelanotide 16mg) in...

Read More
CLINUVEL
Posted by CLINUVEL
June 22, 2018

Trading Halt

22 June 2018 Pursuant to Listing Rule 17.1, Clinuvel Pharmaceuticals Ltd (CUV)...

Read More
CLINUVEL
Posted by CLINUVEL
June 1, 2018

Appendix 3B

01 June 2018 Enclosed is a new issue announcement regarding an application...

Read More
CLINUVEL
Posted by CLINUVEL
May 23, 2018

NICE MAINTAINS ITS POSITION NOT TO RECOMMEND SCENESSE® FOR REIMBURSEMENT

23 May 2018 CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; XETRA-DAX: UR9; NASDAQ INTERNATIONAL...

Read More
CLINUVEL
Posted by CLINUVEL
May 17, 2018

Change in substantial holding

17 May 2018 Enclosed is a notice of a change in substantial...

Read More
CLINUVEL
Posted by CLINUVEL
May 16, 2018

Change in substantial holding

Change in substantial holding Download attachments: 20180516Changeinsubstantialholding.pdf

Read More
CLINUVEL
Posted by CLINUVEL
May 14, 2018

CLINUVEL REGULATORY UPDATE

14 May 2018 CLINUVEL PHARMACEUTICALS LTD  today provided an update on its global...

Read More
CLINUVEL
Posted by CLINUVEL
May 1, 2018

Change in substantial holding

01 May 2018 Enclosed is a notice of a change of interests...

Read More
CLINUVEL
Posted by CLINUVEL
May 1, 2018

CLINUVEL TO TAKE 100% OWNERSHIP OF VALLAURIX

01 May 2018 CLINUVEL PHARMACEUTICALS LTD today announced that it has entered into...

Read More
CLINUVEL
Posted by CLINUVEL
April 30, 2018

Appendix 4C

30 April 2018 CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; XETRA-DAX: UR9; NASDAQ INTERNATIONAL DESIGNATION:...

Read More
CLINUVEL
Posted by CLINUVEL
March 26, 2018

CLINUVEL Newsletter - March 2018

26 March 2018 The erythropoietic protoporphyria (EPP) Expert Meeting in Vienna on...

Read More
CLINUVEL
Posted by CLINUVEL
March 19, 2018

CLINUVEL HOLDS EUROPEAN ERYTHROPOIETIC PROTOPORPHYRIA (EPP) EXPERT MEETING

19 March 2018 CLINUVEL PHARMACEUTICALS LTD today announced the results of the third...

Read More
CLINUVEL
Posted by CLINUVEL
February 21, 2018

CLINUVEL sustains profitability first-half of year

28 February 2018 CLINUVEL PHARMACEUTICALS LTD today announced financial results for the half...

Read More
CLINUVEL
Posted by CLINUVEL
February 13, 2018

CLINUVEL unveils new global positioning

20 February 2018 CLINUVEL PHARMACEUTICALS LTD today released its new global Company positioning...

Read More